Volume 3, Issue 2, 2022
Meet the Editorial Board Member
Article ID: e040322201689
Author(s): David Jay Weber
DOI: 10.2174/266679670302220304094805
Published on: 04 March, 2022
Onco-immunological Aspect of COVID-19: Current Progress and Perceptions
Article ID: e280122200095
Author(s): Suman Kumar Ray and Sukhes Mukherjee*
DOI: 10.2174/2666796703666220107122907
Published on: 01 February, 2022
COVID19 - Far from Over: Call for Urgent Novel and Advanced Measures
Article ID: e280122197574
Author(s): Abhigyan Choudhury and Suprabhat Mukherjee*
DOI: 10.2174/2666796702666211102111805
Published on: 29 November, 2021
Major Drugs Used in COVID-19 Treatment: Molecular Mechanisms, Validation and Current Progress in Trials
Article ID: e030821188723
Author(s): Md. Asaduzzaman Khan*, Shad Bin Islam, Mejbah Uddin Rakib, Didarul Alam, Md. Munnaf Hossen, Mousumi Tania and Asaduzzaman Asad
DOI: 10.2174/2666796701999201204122819
Published on: 04 December, 2020
Impact on Pharmaceutical Industry due to Sudden Pandemic Attack (COVID-19)
Article ID: e280122198187
Author(s): Sudhanshu Mishra, Disha Sharma, Shobhit Prakash Srivastava, Swati Verma and Rishabha Malviya*
DOI: 10.2174/2666796702666211122152928
Published on: 22 December, 2021
A Flash on Cell Therapy Strategies in Clinical Trials against SARS-CoV-2
Article ID: e220122190597
Author(s): Mona Sadat Larijani, Amitis Ramezani, Mohammad Reza Aghasadeghi and Seyed Mehdi Sadat*
DOI: 10.2174/2666796702666210122123559
Published on: 22 January, 2021
Therapeutic Options for the Treatment of 2019-Novel Coronavirus in India: A Review
Article ID: e041220188720
Author(s): Pratyay Kumar Pahari, Sonal Vyas, Shahbaz Aman, Uday Singh, Kusheswar Prasad Singh, Rohit Tiwari and Meenakshi Dhanawat*
DOI: 10.2174/2666796701999201204115545
Published on: 04 December, 2020
Neurovirulence of SARS CoV2: From Clinical Data to Preclinical Neuropsychological Exploration
Article ID: e020221191025
Author(s): Youness Kadil * and Houda Filali
DOI: 10.2174/2666796702666210202124417
Published on: 02 February, 2021
A Critical Appraisal of the Risk of Bias in Systematic Reviews and Metaanalyses Pertaining to COVID-19
Article ID: e301220189630
Author(s): Amit Dang*, Sheshank Madiraju, Jagan Mohan Venkateswara Rao P, Navya Sri Gurram, Sandeep Digijarala, Sumit Dang and Vallish B.N.
DOI: 10.2174/2666796701666201230105144
Published on: 30 December, 2020
An Integrated In Silico Approach to Develop Epitope-Based Peptide Vaccine Against SARS-CoV-2
Article ID: e080221191205
Author(s): Prekshi Garg, Neha Srivastava and Prachi Srivastava*
DOI: 10.2174/2666796702666210208142945
Published on: 08 February, 2021
In Silico Insight into the Inhibitory Effects of Active Antidiabetic Compounds from Medicinal Plants Against SARS-CoV-2 Replication and Posttranslational Modification
Article ID: e180121190410
Author(s): Habibu Tijjani*, Adamu Idris Matinja, Ahmed Olatunde, Maryam Haladu Zangoma, Abubakar Mohammed, Muhammad Akram, Akinwunmi Oluwaseun Adeoye and Hamza Lawal
DOI: 10.2174/2666796702666210118154948
Published on: 18 January, 2021
